All posts by: Michael Zand

About Michael Zand

‘Mini-gene’ therapy relieves features of Rett syndrome in mice – Spectrum

Continue reading

2017-10-11 NEWS

Spectrum

‘Mini-genetherapy relieves features of Rett syndrome in mice
Spectrum
The findings bolster the notion that gene therapy might ease features of Rett syndrome in people with the condition, says lead researcher Adrian Bird, Buchanan Professor of Genetics at the University of Edinburgh in Scotland. “Gene therapy has gone

Continue reading

2017-10-11 NEWS

With GMO Struggle In Mind, Food Industry Vying For Public Trust With CRISPR Discussion
KUNC
The technology is called Clustered Regularly Interspaced Short Palindromic Repeats, or CRISPR. It’s a technique that Alison Van Eenennaam, an animal genetics professor at University of California, Davis, says can de-activate a gene. Or, as she puts it

Continue reading

2017-10-11 NEWS

Rare Disease Report

Part 3 of Gene Therapy Trial for MPS IIIA (Sanfilippo A) Has Begun
Rare Disease Report
On Monday, Rare Disease Report covered the release of new information from Abeona Therapeutics’ gene therapy trial for patients with mucopolysaccharidosis type IIIA (MPS IIIA, Sanfilippo syndrome). One year data from Cohort 1 in the company’s 3-cohort, …

and more »